JOURNAL OF BUON, vol.24, no.1, pp.68-76, 2019 (SCI-Expanded)
Purpose: Colorectal cancer is one of the most common malignancies in the World RAS-BRAF mutational status and primary tumor location are also important factors for the selection of optimal combinations therapies. In this study, we aimed to evaluate the Turkish oncologists' treatment decisions depending on tumor location and mutational status in metastatic colorectal cancer.